Literature DB >> 23820903

Determinants of the heightened activity of glucocorticoid receptor translational isoforms.

Ingrid K Bender1, Yun Cao, Nick Z Lu.   

Abstract

Translational isoforms of the glucocorticoid receptor α (GR-A, -B, -C1, -C2, -C3, -D1, -D2, and -D3) have distinct tissue distribution patterns and unique gene targets. The GR-C3 isoform-expressing cells are more sensitive to glucocorticoid killing than cells expressing other GRα isoforms and the GR-D isoform-expressing cells are resistant to glucocorticoid killing. Whereas a lack of activation function 1 (AF1) may underlie the reduced activity of the GR-D isoforms, it is not clear how the GR-C3 isoform has heightened activity. Mutation analyses and N-terminal tagging demonstrated that steric hindrance is probably the mechanism for the GR-A, -B, -C1, and -C2 isoforms to have lower activity than the GR-C3 isoform. In addition, truncation scanning analyses revealed that residues 98 to 115 are critical in the hyperactivity of the human GR-C3 isoform. Chimera constructs linking this critical fragment with the GAL4 DNA-binding domain showed that GR residues 98 to 115 do not contain any independent transactivation activity. Mutations at residues Asp101 or Gln106 and Gln107 all reduced the activity of the GR-C3 isoform. In addition, functional studies indicated that Asp101 is crucial for the GR-C3 isoform to recruit coregulators and to mediate glucocorticoid-induced apoptosis. Thus, charged and polar residues are essential components of an N-terminal motif that enhances the activity of AF1 and the GR-C3 isoform. These studies, together with the observations that GR isoforms have cell-specific expression patterns, provide a molecular basis for the tissue-specific functions of GR translational isoforms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820903      PMCID: PMC3753425          DOI: 10.1210/me.2013-1009

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  67 in total

1.  Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

3.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

Authors:  J W Funder; P T Pearce; R Smith; A I Smith
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

4.  Domains of the glucocorticoid receptor involved in specific and nonspecific deoxyribonucleic acid binding, hormone activation, and transcriptional enhancement.

Authors:  M Danielsen; J P Northrop; J Jonklaas; G M Ringold
Journal:  Mol Endocrinol       Date:  1987-11

5.  Multiple and cooperative trans-activation domains of the human glucocorticoid receptor.

Authors:  S M Hollenberg; R M Evans
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

6.  Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression.

Authors:  K Dahlman-Wright; T Almlöf; I J McEwan; J A Gustafsson; A P Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

7.  Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans.

Authors:  Yun Cao; Ingrid K Bender; Athanasios K Konstantinidis; Soon Cheon Shin; Christine M Jewell; John A Cidlowski; Robert P Schleimer; Nick Z Lu
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

8.  Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor.

Authors:  K A Hutchison; G Matić; S Meshinchi; E H Bresnick; W B Pratt
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

9.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.

Authors:  R I Scheinman; A Gualberto; C M Jewell; J A Cidlowski; A S Baldwin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes.

Authors:  I Wu; S C Shin; Y Cao; I K Bender; N Jafari; G Feng; S Lin; J A Cidlowski; R P Schleimer; N Z Lu
Journal:  Cell Death Dis       Date:  2013-01-10       Impact factor: 8.469

View more
  8 in total

1.  BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis.

Authors:  J Banuelos; S Shin; Y Cao; B S Bochner; L Morales-Nebreda; G R S Budinger; L Zhou; S Li; J Xin; M W Lingen; C Dong; R P Schleimer; N Z Lu
Journal:  Allergy       Date:  2016-02-04       Impact factor: 13.146

Review 2.  A gradient of glucocorticoid sensitivity among helper T cell cytokines.

Authors:  Jesus Banuelos; Nicholas Z Lu
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-13       Impact factor: 7.638

3.  Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice.

Authors:  Robert H Oakley; Sivapriya Ramamoorthy; Julie F Foley; Jonathan T Busada; Nick Z Lu; John A Cidlowski
Journal:  FASEB J       Date:  2018-04-19       Impact factor: 5.191

Review 4.  Novel Therapies for Eosinophilic Disorders.

Authors:  Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 5.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

Review 6.  The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

Review 7.  Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor.

Authors:  Nicolas C Nicolaides; Evangelia Charmandari; George P Chrousos; Tomoshige Kino
Journal:  BMC Endocr Disord       Date:  2014-08-25       Impact factor: 2.763

8.  Genetically tunable frustration controls allostery in an intrinsically disordered transcription factor.

Authors:  Jing Li; Jordan T White; Harry Saavedra; James O Wrabl; Hesam N Motlagh; Kaixian Liu; James Sowers; Trina A Schroer; E Brad Thompson; Vincent J Hilser
Journal:  Elife       Date:  2017-10-12       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.